144 related articles for article (PubMed ID: 30504817)
1. Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs.
Nalli AD; Brown LE; Thomas CL; Sayers TJ; Porco JA; Henrich CJ
Sci Rep; 2018 Nov; 8(1):17519. PubMed ID: 30504817
[TBL] [Abstract][Full Text] [Related]
2. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.
Luan Z; He Y; He F; Chen Z
Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816
[TBL] [Abstract][Full Text] [Related]
3. Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.
Giaisi M; Köhler R; Fulda S; Krammer PH; Li-Weber M
Int J Cancer; 2012 Aug; 131(4):1003-8. PubMed ID: 21952919
[TBL] [Abstract][Full Text] [Related]
4. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
[TBL] [Abstract][Full Text] [Related]
5. 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression.
Han MA; Woo SM; Min KJ; Kim S; Park JW; Kim DE; Kim SH; Choi YH; Kwon TK
Chem Biol Interact; 2015 Feb; 228():69-78. PubMed ID: 25619640
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
[TBL] [Abstract][Full Text] [Related]
7. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
[TBL] [Abstract][Full Text] [Related]
8. Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression.
Bleumink M; Köhler R; Giaisi M; Proksch P; Krammer PH; Li-Weber M
Cell Death Differ; 2011 Feb; 18(2):362-70. PubMed ID: 20706274
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis.
Wei R; Zhu G; Jia N; Yang W
Cell Biochem Biophys; 2015 May; 72(1):157-64. PubMed ID: 25539708
[TBL] [Abstract][Full Text] [Related]
10. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents.
Sánchez-Pérez T; Ortiz-Ferrón G; López-Rivas A
Cell Death Differ; 2010 May; 17(5):883-94. PubMed ID: 19942932
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
[TBL] [Abstract][Full Text] [Related]
12. Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs.
Huang Y; Yang X; Xu T; Kong Q; Zhang Y; Shen Y; Wei Y; Wang G; Chang KJ
Int J Oncol; 2016 Jul; 49(1):153-63. PubMed ID: 27210546
[TBL] [Abstract][Full Text] [Related]
13. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
14. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins.
Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508
[TBL] [Abstract][Full Text] [Related]
15. Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation.
Henrich CJ; Brooks AD; Erickson KL; Thomas CL; Bokesch HR; Tewary P; Thompson CR; Pompei RJ; Gustafson KR; McMahon JB; Sayers TJ
Cell Death Dis; 2015 Feb; 6(2):e1666. PubMed ID: 25719250
[TBL] [Abstract][Full Text] [Related]
16. Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis.
Ou YC; Li JR; Kuan YH; Raung SL; Wang CC; Hung YY; Pan PH; Lu HC; Chen CJ
Life Sci; 2014 Apr; 100(2):110-117. PubMed ID: 24530290
[TBL] [Abstract][Full Text] [Related]
17. Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression.
Kim S; Seo SU; Min KJ; Woo SM; Nam JO; Kubatka P; Kim S; Park JW; Kwon TK
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004456
[TBL] [Abstract][Full Text] [Related]
18. Targeting eIF4A using rocaglate CR‑1‑31B sensitizes gallbladder cancer cells to TRAIL‑mediated apoptosis through the translational downregulation of c‑FLIP.
Cao Y; He Y; Yang L; Luan Z
Oncol Rep; 2021 Jan; 45(1):230-238. PubMed ID: 33416145
[TBL] [Abstract][Full Text] [Related]
19. Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1.
Lemke J; von Karstedt S; Abd El Hay M; Conti A; Arce F; Montinaro A; Papenfuss K; El-Bahrawy MA; Walczak H
Cell Death Differ; 2014 Mar; 21(3):491-502. PubMed ID: 24362439
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP.
Seo BR; Min KJ; Woo SM; Choe M; Choi KS; Lee YK; Yoon G; Kwon TK
Antioxid Redox Signal; 2017 Aug; 27(4):215-233. PubMed ID: 27927016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
